publication date: May. 30, 2014


Big Ten Cancer Research Consortium Names Executive Officer

was named executive officer of the Big Ten Cancer Research Consortium.

Goodin is executive director for statewide affairs at Rutgers Cancer Institute of New Jersey and professor of medicine at Rutgers Robert Wood Johnson Medical School. She possesses more than 20 years of clinical research leadership experience, including serving as the deputy director of operations, associate director of clinical trials and therapeutics, and director of the Division of Pharmaceutical Sciences at the Cancer Institute of New Jersey.

Goodin will work closely with the consortium’s administrative headquarters, pharmaceutical partners, and other physicians and researchers as well as serve as the primary spokesperson and representative for the consortium at meetings and events.

She played a key role in the establishment of the cancer institute’s clinical practice and designed its clinical research infrastructure, including the Center’s research office, research pharmacy, and protocol review and monitoring system and is a founding co-leader of the Cancer Institute of New Jersey’s statewide clinical trials network that includes 15 hospitals under the Center’s clinical research infrastructure.

Goodin’s research has focused predominantly on the development of both prevention and therapeutic pharmaceutical interventions. She has served as principal investigator on numerous clinical trials, has been published in prestigious journals, and has presented nationally on the topics of cancer treatment, chemoprevention, and supportive care.

Goodin is an active member or board member of the Board of Pharmacy Specialties, American Society of Health-System Pharmacists, American College of Clinical Pharmacy, American Society of Clinical Oncology, and the International Society of Oncology Pharmacy Practice.

Continue reading 40-22 In Brief: Big Ten Research Consortium Names Goodin Executive Officer
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.